Related Experiment Videos
The sequelae of herpes zoster
K Galil1, P W Choo, J G Donahue
1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Mass, USA.
Archives of Internal Medicine
|June 9, 1997
Summary
The incidence of herpes zoster may be increasing, but the risk of complications has remained stable over 40 years. Advanced age and immune compromise increase the risk of herpes zoster complications.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- The incidence of herpes zoster (shingles) has shown a substantial increase over the past four decades.
- This trend necessitates an investigation into potential changes in the associated complication rates.
Purpose of the Study:
- To evaluate whether the risk of complications from herpes zoster has changed over the last 40 years.
- To assess the impact of age and immune status on herpes zoster complication risk.
Main Methods:
- Automated medical records from a health maintenance organization were screened for herpes zoster diagnosis codes.
- Full-text records were sampled to determine the predictive value of herpes zoster diagnoses.
- Records of patients with complication codes underwent full review to identify and analyze adverse outcomes.
Main Results:
- A 60-day risk of 12% for complications was observed in 859 individuals with herpes zoster, adjusted to 14% after sensitivity analysis.
- The risk of complications increased significantly with age, with individuals over 64 years old having over six times the risk of those under 25.
- Trigeminal rash distribution and conditions associated with immune compromise were identified as risk factors for complications.
Conclusions:
- Despite an apparent rise in herpes zoster incidence, the risk of specific or overall complications has not changed in this population-based sample.
- Advanced age and conditions linked to diminished cellular immunity are associated with a higher likelihood of experiencing complicated herpes zoster.
- These findings underscore the importance of considering age and immune status in managing herpes zoster patients.